Skip to Main Content

Paper Details

Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
Ann Clin Transl Neurol
17
2021
COVID-19, MS, NID, PwNID, depression, liver disease, multiple sclerosis, neuroinflammatory diseases, neuroinflammatory disorders, neurological disability, participants, patient, persons
Author NameAffiliation
Wendy S VargasMultiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center
Wendy S VargasNew York Presbyterian Hospital
Erin E LongbrakeYale University
Zongqi XiaUniversity of Pittsburgh
Zongqi XiaUniversity of Pittsburgh
Philip L De JagerMultiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center
Philip L De JagerNew York Presbyterian Hospital
Philip L De JagerMultiple Sclerosis Center and Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center
Philip L De JagerNew York Presbyterian Hospital
  • 1 - 9

Datasets